Home Stocks Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals Ltd

The live share price of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) as on 21 Sep 9:59am is ₹416.55 from NSE/BSE.

JAGSNPHARM NSE

₹416.55 ▼-1.16% (-4.9)

As on Sep 21, 2023 03:29 PM IST

How do you feel today about Jagsonpal Pharmaceuticals Ltd?

Bearish or

Bullish

Bearish or

Bullish

Key Metrics

PE Ratio

36.17

PB Ratio

7.12

Dividend Yield

1.16%

Sector PB

4.76

Sector PE

40.59

Sector Div Yld

0.77%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Smallcap, ₹1,131 Cr

Jagsonpal Pharmaceuticals Limited is engaged in pharmaceutical business. It specializes in developing and manufacturing bulk drugs and pharmaceutical formulations.

The following charts display the financial performance of the Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Smallcap, ₹1,131 Cr

Financials

Income Statement

(INR)		Y/Y Change
Revenue	242 Cr	+9.7%
Operating Expense	10 Cr	+25.7%
Net Income	26 Cr	+41.7%
Net Profit Margin	11.02%	+29.19%
Earning Per Share	10	+41.76%
EBITDA	36 Cr	+28.01%

Balance sheet

(INR)		Y/Y Change
Cash & short-term Inv	114 Cr	+143.58%
Total Assets	194 Cr	+18.7%
Total Liabilities	36 Cr	+14.58%
Total Equity	158 Cr	+19.68%
Shares Outstanding	2.62 Cr	+0.01%
Price to Book	4.78	-29.77%
Return on Assets	14.87%	+29.53%
Return on Capital	22.16 Cr	+9.27%

Cash Flows

(INR)		Y/Y Change
Net Income	26 Cr	+41.7%
Cash from Operations	46 Cr	+575.25%
Cash from Investing	-57 Cr	+123.7%
Cash from Financing	0 Cr	-97.38%
Net Change in Cash	-11 Cr	-68.51%
Free Cash Flow	46 Cr	+690.78%

Shareholding Pattern

Total Promoter Holding

68.71%

Unpledged

Foreign Institutions

0.37%

Foreign Institutions

Retail & Others

30.09%

Retail & Others

Other Parties

Other Domestic Institutions

0.83%

Insurance Firms

Others

Mutual Funds

0%

Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

32.64

1Y Return

▲26.6%

CIPLA

Cipla Ltd

PE Ratio

32.19

1Y Return

▲12.71%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

20.18

1Y Return

▲36.5%

MANKIND

Mankind Pharma Ltd

PE Ratio

47.07

1Y Return

▲22.32%

FAQs on Jagsonpal Pharmaceuticals Ltd

How to buy Jagsonpal Pharmaceuticals Ltd stocks?

You can easily buy the stocks/shares of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Jagsonpal Pharmaceuticals Ltd?

The stock price of Jagsonpal Pharmaceuticals Ltd as on 21 Sep 2023 is ₹416.55

What is the 52-week High and Low of Jagsonpal Pharmaceuticals Ltd?

The 52-week high and low of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is ₹514.85 and ₹285.

What is the PE and PB ratio of Jagsonpal Pharmaceuticals Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Jagsonpal Pharmaceuticals Ltd are 36.17 and 7.12 respectively.

What are the peers or stocks similar to Jagsonpal Pharmaceuticals Ltd?

The peers or stocks similar to Jagsonpal Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Mankind Pharma Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Jagsonpal Pharmaceuticals Ltd belong to?

Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) belongs to the Pharmaceuticals sector.

What is the Market Cap of Jagsonpal Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is ₹1,131 Cr as of 21 Sep 2023

Can't decide whether or not to buy Jagsonpal Pharmaceuticals Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.

Dislaimer: This platform is intended for informational purposes only and is not intended to provide investment advice. The stock prices displayed are delayed and may not reflect the most current market conditions. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. You can also consider consulting a financial advisor before making any investment decisions. Smallcase Technologies Private Limited shall not be responsible for any losses that may occur as a result of using this platform.